Clinical Trials Sponsored by Get.On

Total 114 results

Aetion, Inc.

Completed

Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

Metastatic Lung Cancer | Non-small Cell Lung Cancer

United States
Aetion, Inc.

Completed

Dexamethasone and COVID-19 Inpatient Mortality

Coronavirus

United States
Aetion, Inc.

Active, not recruiting

Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments

COVID-19

United States
Gedeon Richter Plc.

Completed

Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta

Bioequivalence

United Kingdom
Gedeon Richter Plc.

Completed

Cariprazine: Comparison of Slow- and Immediate-release Forms

Pharmacokinetic Profile

United Kingdom
Gedeon Richter Plc.

Unknown

Comparative Pharmacokinetic Trial of RGB-03 and MabThera

Rheumatoid Arthritis
Gedeon Richter Plc.

Recruiting

Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

Schizophrenia

Mexico, United States, Bulgaria, Colombia, Romania, Russian Federation, Serbia, Ukraine
Gedeon Richter Plc.

Completed

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

Poland, United States, Spain, Hungary, Italy, Czechia, Bulgaria, Ukraine
Gedeon Richter Plc.

Recruiting

Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

Prader-Willi Syndrome

United States, Spain, Czechia, Italy, France
AstraZeneca
Aetion, Inc.

Withdrawn

A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy (O-STEREO)

Pregnancy | Pregnant Women | Pregnancy Outcome
Gedeon Richter Plc.

Completed

A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

Healthy

United Kingdom
Gedeon Richter Plc.

Completed

A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy Adults

Healthy Volunteers; | Obese, Otherwise Healthy Volunteers

United Kingdom
Geron Corporation

Completed

Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis | Myeloid Malignancies

United States
Geron Corporation

Completed

Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera (ET/PV)

Polycythemia Vera | Essential Thrombocythemia

United States, Germany, Switzerland
Geron Corporation

Completed

Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States, Canada, Germany
Geron Corporation

Completed

Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma

Multiple Myeloma

United States
Geron Corporation

Completed

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

Chronic Lymphoproliferative Diseases

United States
Geron Corporation

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis

Myelofibrosis

United States
Geron Corporation

Recruiting

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

Myelofibrosis

United States, Australia, Italy, India, United Kingdom, Israel, Taiwan, Poland, Malaysia, Argentina, Spain, Turkey, Belgium, Germany, Austria, Brazil, Bulgaria, Colombia, Denmark, France, Georgia, Hungary, Korea, Republic of, Portugal, ... and more
Geron Corporation

Available

Expanded Access for Treatment With Imetelstat

Myelodysplastic Syndromes
Geron Corporation

Completed

Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma

Multiple Myeloma

United States
Geron Corporation

Completed

Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies

Solid Tumor Malignancies

United States
Geron Corporation

Completed

A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer

Breast Cancer

United States
Geron Corporation

Active, not recruiting

Study to Evaluate Imetelstat (GRN163L) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

United States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
Geron Corporation

Completed

Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor

Myelofibrosis

United States, France, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Korea, Republic of, Canada
Geron Corporation

Completed

Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma

Multiple Myeloma

United States
Geron Corporation

Completed

Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer

Locally Recurrent or Metastatic Breast Cancer

United States, Canada
Geron Corporation

Completed

Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer

Lung Cancer

United States
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Gedeon Richter Slovakia, s.r.o.

Completed

Trial Protocol GlobiFer - Oral Iron Repletion (TPG)

Iron Deficiency

Slovakia
AbbVie
Gedeon Richter Plc.

Recruiting

Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants

Healthy Participants | Generalized Anxiety Disorder (GAD)

United States
Seton Hall University

Not yet recruiting

A Pilot Intervention Study to Promote Functional Health in Women

Health Behavior

United States
Seton Healthcare Family

Terminated

Comparison of Nebulizers in ED in Pediatric Asthma Patients

Asthma

United States
Seton Healthcare Family

Completed

Topical Steroid Formulation and Wet Wraps

Dermatitis, Atopic

United States
Seton Healthcare Family

Completed

PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei

Scabies

United States
Seton Healthcare Family

Completed

Efficacy of Tyrosine in Restless Legs Syndrome

Restless Legs Syndrome (RLS)

United States
Seton Healthcare Family

Completed

A Randomized Control Trial for Preventative Scar Management

Hypertrophic Scarring

United States
Seton Healthcare Family

Withdrawn

Effect of Music Therapy on Cognitive Recovery

Epilepsy

United States
Seton Healthcare Family

Completed

BIO4 Clinical Case Study: Cervical Spine

Degenerative Disc Disease | Spondylolisthesis | Trauma (Including Fractures)

United States
Seton Hall University

Unknown

Improve Functional Health Status in Minority Women With HIV

HIV/AIDS

United States
Seton Healthcare Family

Withdrawn

Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease (CAPP)

Irritable Bowel Syndrome (IBS)

United States
Seton Healthcare Family

Terminated

Satisfaction Rates Among Parents of Children With Autism in the ED (ASD)

Autism Spectrum Disorder

United States
Seton Healthcare Family

Completed

The Treatment of Depression With Botulinum Type A Toxin

Depression

United States
Seton Healthcare Family

Withdrawn

A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families

Atopic Dermatitis

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Depression, Bipolar

United States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Mania | Bipolar I Disorder

United States, Croatia, Romania, Russian Federation, Serbia, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico

Clinical Trials Sponsored by Get.On

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations